文献速递呼吸衰竭与机械通气儿科与产科急症

极早产儿(胎龄<27周)采用微创肺表面活性物质给药与结局的相关性

Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.
PubMed 文献 · JAMA Netw Open · 2022-08-01
一句话结论德国68个三级NICU的队列研究显示,胎龄<27周极早产儿接受LISA与全因死亡、BPD及BPD或死亡复合结局风险降低相关。

该研究基于德国新生儿网络2009年4月1日至2020年12月31日68个三级NICU的队列数据,纳入胎龄22周0天至26周6天的极早产儿6542例,比较生后72小时内接受LISA与未接受LISA者的短期结局。2534例(38.7%)接受LISA,其中1357例(53.6%)在生后72小时内无需机械通气,而未接受LISA者中仅331例(8.3%)无需机械通气。校正胎龄、小于胎龄儿、性别、多胎、院内出生、产前激素使用及生后12小时内最大吸入氧浓度后,LISA与全因死亡(OR 0.74;95%CI 0.61-0.90;P=.002)、BPD(OR 0.69;95%CI 0.62-0.78;P<.001)及BPD或死亡(OR 0.64;95%CI 0.57-0.72;P<.001)风险降低相关。作者认为LISA可能与极早产儿不良结局风险降低相关。

要点

  • 6542例胎龄<27周极早产儿中2534例(38.7%)接受LISA,多在产房管理中近似预防性给药。
  • 接受LISA者1357例(53.6%)生后72小时内无需机械通气,未接受LISA者仅331/4008例(8.3%)无需机械通气。
  • 校正混杂后LISA与全因死亡风险降低相关(OR 0.74;95%CI 0.61-0.90;P=.002)。
  • 校正混杂后LISA与BPD风险降低相关(OR 0.69;95%CI 0.62-0.78;P<.001),与BPD或死亡复合结局风险降低相关(OR 0.64;95%CI 0.57-0.72;P<.001)。

适用人群与场景

  • 德国68个三级新生儿重症监护病房收治的胎龄22周0天至26周6天的极早产儿,出生时间2009年4月1日至2020年12月31日。
  • 研究比较生后72小时内接受LISA与未接受LISA的婴儿,暴露为生后72小时内使用LISA。

诊断标准与关键阈值

  • LISA失败定义为生后72小时内需要机械通气。

处置流程与药物剂量

  • LISA最常在产房管理中近似预防性给予。

研究设计与关键结果

  • 研究类型为基于德国新生儿网络数据的队列研究,纳入68个三级NICU的6542例极早产儿(3030例[46.3%]女性,3512例[53.7%]男性;平均[SD]胎龄25.3[1.1]周;平均[SD]出生体重715[180]g)。
  • 2534例(38.7%)接受LISA;接受LISA者中1357例(53.6%)生后72小时内无需机械通气,未接受LISA的4008例中仅331例(8.3%)无需机械通气。
  • 多因素logistic回归校正胎龄、小于胎龄儿状态、性别、多胎、院内出生、产前激素使用及生后12小时内最大吸入氧浓度后,LISA与全因死亡风险降低相关(OR 0.74;95%CI 0.61-0.90;P=.002)。
  • 同一模型显示LISA与BPD风险降低相关(OR 0.69;95%CI 0.62-0.78;P<.001),与BPD或死亡复合结局风险降低相关(OR 0.64;95%CI 0.57-0.72;P<.001)。
  • 主要结局还包括气胸、早产儿视网膜病变、颅内出血及脑室周围白质软化。

证据类型、等级与局限

  • 证据类型为大规模观察性队列研究,作者结论为LISA可能与极早产儿不良结局风险降低相关。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在这项长期多中心队列研究中,LISA可能与极早产儿不良结局风险降低相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The inclusion of less invasive surfactant administration (LISA) in the care of preterm infants has been found to be beneficial for respiratory outcomes. Recently, the OPTIMIST trial found higher mortality rates in the subgroup of infants born at 25 to 26 weeks' gestational age (GA) who received surfactant treatment while spontaneously breathing.

OBJECTIVE: To analyze outcomes among LISA-exposed, highly vulnerable babies born at less than 27 weeks' GA within the large-scale observational cohort of the German Neonatal Network.

DESIGN, SETTING, AND PARTICIPANTS: In this cohort study of data from 68 tertiary level neonatal intensive care units in Germany of infants born between 22 weeks 0 days to 26 weeks 6 days of gestation between April 1, 2009, and December 31, 2020, short-term outcomes among infants receiving LISA vs infants not receiving LISA were compared.

EXPOSURE: Use of LISA within the first 72 hours of life.

MAIN OUTCOMES AND MEASURES: The main outcomes were rates of LISA use, use of mechanical ventilation within the first 72 hours (considered failure of LISA), and association of LISA with outcomes, including death from all causes, bronchopulmonary dysplasia (BPD), death and BPD combined, pneumothorax, retinopathy of prematurity, intracerebral hemorrhage, and periventricular leukomalacia. To address potential confounding factors, multivariate logistic regression models were used.

RESULTS: A total of 6542 infants (3030 [46.3%] female and 3512 [53.7%] male; mean [SD] GA, 25.3 (1.1) weeks; mean [SD] birth weight, 715 [180] g) were analyzed; 2534 infants (38.7%) received LISA, which was most frequently given quasi-prophylactically during delivery room management. Among the infants who received LISA, 1357 (53.6%) did not require mechanical ventilation in the first 72 hours compared with 331 infants (8.3%) of 4008 who did not receive LISA. In a multivariate logistic regression model that adjusted for GA, small-for-GA status, sex, multiple birth, inborn status, antenatal steroid use, and maximum fraction of inspired oxygen in the first 12 hours of life, LISA was associated with reduced risks of all-cause death (odds ratio [OR], 0.74; 95% CI, 0.61-0.90; P = .002), BPD (OR, 0.69; 95% CI, 0.62-0.78; P < .001), and BPD or death (OR, 0.64; 95% CI, 0.57-0.72; P < .001) compared with infants without LISA exposure.

CONCLUSIONS AND RELEVANCE: The results of this long-term multicenter cohort study suggest that LISA may be associated with reduced risks of adverse outcomes in extremely preterm infants.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Härtel C, Herting E, Humberg A, et al. Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation. JAMA Netw Open. 2022. PMID: 35943742. doi:10.1001/jamanetworkopen.2022.25810

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。